2
|
Baker E, Kim B, Rattay T, Williams K, Ives C, Remoundos D, Holcombe C, Gardiner MD, Jain A, Sutton R, Achuthan R, Turton P, Fairbrother P, Brock L, Aggarwal S, Basu N, Murphy J, Trickey A, Macmillan RD, Potter S. The TeaM ( Th er apeutic Mammaplasty) study: Protocol for a prospective multi-centre cohort study to evaluate the practice and outcomes of therapeutic mammaplasty. Int J Surg Protoc 2016; 1:3-10. [PMID: 31851757 PMCID: PMC6913574 DOI: 10.1016/j.isjp.2016.08.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2016] [Revised: 08/20/2016] [Accepted: 08/20/2016] [Indexed: 11/15/2022] Open
Abstract
Multicentre prospective study involving breast and plastic surgical units across the UK. Will produce valuable data regarding the practice and outcomes of therapeutic mammaplasty. Will inform decision-making and lead to future definitive study. Will strengthen the collaborative network to facilitate the delivery of future projects. Will increase awareness of the techniques among trainees such that participation is educational.
Introduction Wide local excision and adjuvant radiotherapy is the standard of care for early breast cancer. For large tumours, however, mastectomy is frequently recommended as conventional breast-conserving techniques often result in poor cosmetic outcomes. Therapeutic mammaplasty (TM) may extend the boundaries of breast-conserving surgery by combining breast reduction and mastopexy techniques with tumour excision, preserving a natural breast shape and avoiding the need for mastectomy. The prevalence of this operative option among surgeons in the UK and its success rate are unknown. The TeaM study is a multicentre prospective study that aims to investigate the practice and outcomes of TM. Methods and analysis Breast centres performing TM will be invited to participate through the research collaborative network and the professional associations. All patients undergoing TM between September 2016 and March 2017 will be included. Demographic, operative, oncological and complication data within 30-days of surgery will be collected. The primary outcome will be unplanned re-operation for complications. Secondary outcomes will include unplanned readmission, re-excision rates and time to adjuvant therapy. Prospective data on 500 patients from 50 centres are anticipated. Exploratory analyses will identify predictors for complications and inform the design of a definitive study. Ethics and dissemination Research ethics approval is not required for this study. This has been confirmed by the on-line Health Research Authority decision tool. This study will provide novel information regarding the practice and outcomes of TM in the UK. This will inform decision-making for patients and surgeons and inform future research. Dissemination of the study protocol will be via the Mammary Fold Academic and Research Collaborative, the Reconstructive Surgery Trials Network and the professional associations, the Association of Breast Surgery and British Association of Plastic, Reconstructive and Aesthetic Surgeons. Results will be presented at relevant surgical conferences and published in peer-reviewed journals.
Collapse
Affiliation(s)
- Elizabeth Baker
- Breast Unit, Bradford Teaching Hospitals, Duckworth Lane, Bradford BD9 6RJ, UK
| | - Baek Kim
- Department of Breast Surgery, St. James's University Hospital, Beckett Street, Leeds LS9 7TF, UK
| | - Tim Rattay
- Department of Cancer Studies, Clinical Sciences Building, University of Leicester, Leicester LE2 2LX, UK
| | - Kathryn Williams
- Nightingale Breast Unit, University Hospital of South Manchester NHS Foundation Trust, Southmoor Road, Manchester M23 9LT, UK
| | - Charlotte Ives
- Torbay and South Devon NHS Foundation Trust, Newton Road, Torquay, Devon TQ2 7AA, UK
| | - Dennis Remoundos
- Oxford University Hospitals NHS Foundation Trust, Headley Way, Headington, Oxford OX3 9DU, UK
| | - Chris Holcombe
- Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital, Prescot Street, Liverpool L7 8XP, UK
| | - Matthew D Gardiner
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxford OX3 7HE, UK.,Department of Surgery and Cancer, Imperial College London, SW7 2AZ, UK
| | - Abhilash Jain
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxford OX3 7HE, UK.,Imperial College London NHS Trust, London SW7 2AZ, UK
| | - Richard Sutton
- Royal United Hospital NHS Foundation Trust, Combe Park, Bath, Avon BA1 3NG, UK
| | - Rajgopal Achuthan
- Breast Unit, Bradford Teaching Hospitals, Duckworth Lane, Bradford BD9 6RJ, UK
| | - Philip Turton
- Breast Unit, Bradford Teaching Hospitals, Duckworth Lane, Bradford BD9 6RJ, UK
| | | | - Lisa Brock
- Nottingham Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK
| | - Shweta Aggarwal
- Whipps Cross University Hospital, Whipps Cross Road, Leytonstone, London E11 1NR, UK
| | - Naren Basu
- Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham B15 2TH, UK
| | - John Murphy
- Nightingale Breast Unit, University Hospital of South Manchester NHS Foundation Trust, Southmoor Road, Manchester M23 9LT, UK
| | - Adam Trickey
- Bristol Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, 39 Whatley Road, Clifton, Bristol BS8 2PS, UK
| | - R Douglas Macmillan
- Nottingham Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK
| | - Shelley Potter
- Bristol Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, 39 Whatley Road, Clifton, Bristol BS8 2PS, UK
| | | | | |
Collapse
|